Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity.

Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity. Expert Opin Drug Saf. 2019 May 16;: Authors: Bello NT PMID: 31092063 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31092063?dopt=Abstract

Source: Expert Opinion on Drug Safety - May 17, 2019 Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research

More News: Bupropion | Drugs & Pharmacology | Eating Disorders & Weight Management | Obesity | Wellbutrin